12
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Depletion of Patients' Plasma Tryptophan Using Tryptophan Side-Chain Oxidase Columns

, , , , , , , & show all
Pages 252-257 | Published online: 11 Jun 2009

References

  • Kidd J G. Regression of transplanted lymphomas as induced in vivo by means of normal guinea pig serum. I. Cause of various transplanted cancers in mice and rat given guinea pig serum or rabbit serum. J Exp Med 1953; 98: 565–581
  • Broom J D. Evidence that the L-asparaginase activity in guinea pig serum is responsible for its antilymphoma effects. Nature 1961; 191: 114–115
  • Roberts J. Therapy of neoplasia by deprivation of essential amino acids. Enzymes as Drugs, JS Holcenberg, J Roberts. Wiley, New York 1981; 63–76
  • Sidransky S. Effects of tryptophan on protein synthesis by liver. Nutritional Diseases: Research Directions in Comparative Pa thobiology, DG Scarpelli, G Migaki. Alan R. Liss, New York 1986; 71–90
  • Wooley P V, Dion R L, Bono V H. Effects of tryptophan deprivation on L1210 cells in culture. Cancer Res 1974; 34: 1010–1014
  • Roberts J, Rosenfeld H J. Isolation, crystallization. and properties of indolyl-3-alkane alpha-hydroxylase: A novel tryptophan-me-tabolizing enzyme. J Biol Chem 1977; 252: 2640–2647
  • Takai K, Ushiro H, Noda Y. Crystalline hemoprotein from Pseudomonas that catalyzes oxidation of side chain of tryptophan and other indole derivatives. J Biol Chem 1977; 252: 2648
  • Schmer G, Roberts J. Purification on indoyl-3-alkane α-hydrox-ylase by affinity chromatography on indoyl-agarose columns. Biochim Biophys Acta 1978; 527: 264–271
  • Farin F M, Chandler W, Kidd P G. The antineoplastic activity of a unique tryptophan depeleting enzyme indolyl-3-alkane alpha-hydroxylase. Am J Clin Pathol 1987; 87: 413
  • Roberts J, Schmid F A, Rosenfeld H J. Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan and L-histidine. Cancer Treat Rep 1979; 63: 1045–1054
  • Schmer G, Ostrander E, Roberts J. The removal of cancer nutrients from plasma by plasmapheresis combined with enzyme reactors. Plasma Separation and Plasma Fractionation: Current Status and Future Directions, MJ Lysaght, HJ Gurland. Karger, Basel 1983; 284–297
  • Schmer G, Dennis M B, Hsueh S. The synthesis of L-tryptophan-degrading enzyme. Int J Artif Organs 1990; 13: 316–320
  • Roberts R R, Gilbert J, Rodewalt L L. Modem Experimental Organic Chemistry. Saunders, Philadelphia 1985; 700–701
  • Kellogg R M, Hester J P. Kinetics modeling of plasma exchange: Intra-and post-plasma exchange. Plasma Ther Transfus Technol 1987; 8: 283–290
  • Hill J M, Roberts J, Loeb E. L-Asparaginase therapy for leukemia and other malignant neoplasms. JAMA 1967; 202: 382–888
  • Ho D H, Brown N S, Yen A. Clinical pharmacology of polyethylene glycol-L-asparaginase. Drug Metab Dispos 1986; 14: 349–352
  • Ho Freie D H. Clinical pharmacologic studies of L-asparaginase. Clin Pharmacol Ther 1970; 11: 408–417
  • Byrne G I, Lehmann L K, Kirschbaum J C. Induction of tryptophan degradation in vitro and in vivo: A gamma-interferon-induced activity. J Interferon Res 1986; 6: 389–396

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.